Skip to main content
رجوع
SHPPF logo

Redcare Pharmacy N.V.

جودة البيانات: 100%
ذروة بيع
SHPPF
OTC Healthcare Medical - Pharmaceuticals
KWD 45.18
KWD 0.00 (0.00%)
القيمة السوقية: 919.02M
مُدرج أيضًا باسم SAEYY OTC
نطاق اليوم
KWD 45.18 KWD 62.99
نطاق 52 أسبوعًا
KWD 45.18 KWD 148.22
حجم التداول
400
متوسط 50 يوم / 200 يوم
KWD 66.04 / KWD 102.10
الإغلاق السابق
KWD 45.18

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -24.4 0.4
P/B 2.0 2.9
ROE % -8.0 3.8
Net Margin % -1.3 3.9
Rev Growth 5Y % 29.0 10.0
D/E 0.9 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 10.137
KWD 9.775 – KWD 10.959
5.2 B 1
FY2029 KWD 6.735
KWD 6.495 – KWD 7.281
4.6 B 1
FY2028 KWD 2.394
KWD 2.309 – KWD 2.588
4.1 B 1

النقاط الرئيسية

Revenue grew 29.04% annually over 5 years — strong growth
Negative free cash flow of -56.28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.03%
Capital efficient — spends only 2.70% of revenue on capex

النمو

Revenue Growth (5Y)
29.04%
Revenue (1Y)24.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-7.99%
ROIC-2.04%
Net Margin-1.28%
Op. Margin-0.81%

الأمان

Debt / Equity
0.91
Current Ratio1.55
Interest Coverage-1.17

التقييم

P/E Ratio
-24.39
P/B Ratio2.00
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 24.01% Revenue Growth (3Y) 27.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 29.04% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.94B Net Income (TTM) -37.69M
ROE -7.99% ROA -3.02%
Gross Margin 20.19% Operating Margin -0.81%
Net Margin -1.28% Free Cash Flow (TTM) -56.28M
ROIC -2.04% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.91 Current Ratio 1.55
Interest Coverage -1.17 Dividend Yield 0.00%
Valuation
P/E Ratio -24.39 P/B Ratio 2.00
P/S Ratio 0.31 PEG Ratio 1.97
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 919.02M Enterprise Value 1.24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.94B 2.37B 1.80B 1.20B 1.06B
Net Income -37.69M -45.46M -12.04M -77.65M -74.19M
EPS (Diluted) -1.87 -2.26 -0.63 -4.32 -4.15
Gross Profit 593.48M 545.78M 440.38M 331.79M 266.53M
Operating Income -23.79M -38.99M -17.30M -69.17M -65.70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.25B 1.00B 1.02B 729.47M 783.08M
Total Liabilities 767.01M 493.32M 469.56M 374.84M 367.66M
Shareholders' Equity 459.03M 483.98M 522.19M 354.63M 415.41M
Total Debt 415.44M 247.38M 244.84M 255.19M 236.43M
Cash & Equivalents 92.37M 96.61M 83.78M 66.44M 247.08M
Current Assets 619.17M 500.02M 499.52M 343.92M 432.76M
Current Liabilities 399.85M 249.73M 223.72M 119.31M 124.09M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#105 of 616
66
Custom Full Throttle
#96 of 146
35

النشاط الأخير

دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل Full Throttle
Mar 24, 2026